innoscripta SE (ISIN: DE000A40QVM8) has launched operations in the United Kingdom, marking its second major international expansion following a successful entry into France earlier this year. The German software company has established a dedicated local sales team and secured its first UK customer, a software firm with annual revenues in the mid-double-digit million euro range, which will use innoscripta's SaaS platform Clusterix to manage its R&D tax relief claims.
Clusterix is designed to systematically capture R&D projects, working hours and eligible costs while creating comprehensive, audit-ready documentation. This capability is increasingly critical as HM Revenue & Customs (HMRC) has significantly tightened documentation and compliance requirements for R&D tax relief claims in recent years. The platform has been fully adapted to UK regulatory requirements to meet local standards.
The UK represents a substantial opportunity for innoscripta, with annual R&D tax reliefs of approximately EUR 8.7 billion (about 0.3% of GDP), making it roughly seven times larger than Germany and, alongside France, one of Europe's largest R&D tax incentive markets. The company plans to significantly expand its UK sales organization and customer base by the end of the year, with several additional customer engagements already at an advanced stage of negotiations.
innoscripta SE offers Clusterix as a scalable software platform for the structured organization and management of research and development activities. Companies use the platform to efficiently manage innovation projects, digitize internal processes, and make their R&D activities transparent and scalable. The expansion into the UK follows the company's earlier announcement on April 15, 2026, regarding its market entry into France.
For more information, view the original release on NewMediaWire.
